Get 20% lifetime commission for referring investors to digrin.com
here.
Kezar Life Sciences, Inc. (KZR) Financials
Stock symbol KZR is outdated, potentially delisted? Maybe it is available on other exchange?
KZR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 68.0 million | 2.8 million |
| Dec. 31, 2025 | 76.6 million | 6.6 million |
| Sept. 30, 2025 | 97.7 million | 14.8 million |
| June 30, 2025 | 109.1 million | 17.3 million |
KZR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -7.4 million | 653000 |
| Dec. 31, 2025 | -12.0 million | 1.6 million |
| Sept. 30, 2025 | -9.8 million | 2.1 million |
| June 30, 2025 | -12.8 million | 2.4 million |
KZR Net Income
No data available :(
KZR Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 66.2 million | - | - |
| Dec. 31, 2025 | 71.9 million | - | 2.3 million |
| Sept. 30, 2025 | 90.2 million | 1.4 million | 3.3 million |
| June 30, 2025 | 100.8 million | 2.6 million | 344000 |
KZR Shares Outstanding
KZR Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 1.5 million | 5.2 million | - |
| Dec. 31, 2025 | - | 5.1 million | 3.2 million | - |
| Sept. 30, 2025 | - | 6.9 million | 4.8 million | - |
| June 30, 2025 | - | 9.6 million | 5.0 million | - |
KZR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | - |
| Dec. 31, 2025 | - | 176000 |
| Sept. 30, 2025 | - | 227000 |
| June 30, 2025 | - | - |
KZR
Price: $7.29
52 week price:
Earnings Per Share: -6.17 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 409400
Market Capitalization: 53.9 million